People without diabetes are increasingly using blood sugar monitoring devices originally designed for diabetic patients to track their metabolic health and optimise their lifestyle choices.
Sarah from Maidstone checks her phone app every morning to see how her blood sugar responded to last night’s dinner. She doesn’t have diabetes. Like a growing number of people here in Kent, she’s using a continuous glucose monitor – a small sensor that tracks blood sugar levels throughout the day – as part of a wellness routine aimed at better energy levels and weight management.
These devices, which revolutionised diabetes care by eliminating the need for frequent finger-prick tests, are now finding their way onto the arms of healthy individuals seeking insights into how their bodies respond to different foods and activities.
The Technology Behind the Trend
Continuous glucose monitors provide real-time data through wearable sensors that measure glucose levels in tissue fluid. Originally designed as medical devices for people with diabetes, over-the-counter versions like the Dexcom Stelo are now available without prescription specifically for non-diabetics focusing on fitness, energy management and weight loss.
Wellness apps such as Levels, Signos and Veri pair these monitors with data interpretation services, guiding users through dietary and activity adjustments based on their glucose patterns. The idea is simple: understand how your body responds to different foods and make changes accordingly.
Small studies suggest the approach might have merit. Research involving 473 non-diabetic participants using CGMs with a wellness app showed significant improvements in time spent within target glucose ranges over just 10 days. Users reported increased awareness of how lifestyle choices affected their blood sugar levels.
Medical Opinion Remains Mixed
But medical experts remain cautious about the trend. Specialists from institutions like Harvard and Johns Hopkins point to limited evidence that glucose monitoring improves health outcomes in people without diabetes. They worry about over-medicalisation of normal biological processes without proven benefits.
The diabetes community has raised different concerns. With roughly 7 million people in England living with diabetes, some worry that non-diabetic use could strain supply chains and access for type 1 diabetes patients who rely on CGMs as essential medical devices.
There’s also the question of data interpretation. Glucose levels naturally fluctuate throughout the day in healthy individuals, and without proper medical context, users might misinterpret normal variations as concerning spikes.
Regulation and Access
In the UK, CGMs designed for diabetes management are regulated as medical products by the Medicines and Healthcare products Regulatory Agency. Over-the-counter versions marketed for wellness face lighter regulatory requirements, reflecting their non-medical positioning.
NHS Kent and Medway Integrated Care Board promotes lifestyle interventions for metabolic health but doesn’t routinely fund CGMs for non-diabetic use. Private options remain available through pharmacies and online retailers.
Source: @bmj_latest
Key Takeaways
- Continuous glucose monitors originally designed for diabetes care are being adopted by healthy individuals for wellness tracking
- Small studies show potential benefits for lifestyle awareness, but medical experts question whether monitoring improves health outcomes in non-diabetics
- Over-the-counter versions are available privately, but NHS funding focuses on medically necessary use for diabetes patients
What This Means for Kent Residents
Kent residents considering CGM use for wellness should consult their GP before starting, above all to understand how to interpret the data correctly and avoid unnecessary anxiety over normal glucose fluctuations. While private purchase options exist through local pharmacies and online, the cost may be significant for ongoing use. Those concerned about metabolic health, prediabetes risk, or weight management can access NHS-funded lifestyle intervention programmes through their local practice, which may provide more evidence-based support than self-directed glucose monitoring.